FDA Inspection 773233 — UCLA Health, UCLA Blood & Platelet Center

UCLA Health, UCLA Blood & Platelet Center — FEI 3004048013

The FDA completed an inspection of UCLA Health, UCLA Blood & Platelet Center on March 20, 2012 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 20, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
20821 CFR 640.3(a)(1)Donor suitability procedures not followed